These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31242287)

  • 1. HDAC inhibitors to the rescue in sonic hedgehog medulloblastoma.
    Becher OJ
    Neuro Oncol; 2019 Sep; 21(9):1091-1092. PubMed ID: 31242287
    [No Abstract]   [Full Text] [Related]  

  • 2. A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma.
    Pak E; MacKenzie EL; Zhao X; Pazyra-Murphy MF; Park PMC; Wu L; Shaw DL; Addleson EC; Cayer SS; Lopez BG; Agar NYR; Rubin LL; Qi J; Merk DJ; Segal RA
    Neuro Oncol; 2019 Sep; 21(9):1150-1163. PubMed ID: 31111916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDACs and MYC in medulloblastoma: how do HDAC inhibitors control MYC-amplified tumors?
    Shofuda T; Kanemura Y
    Neuro Oncol; 2021 Feb; 23(2):173-174. PubMed ID: 33394043
    [No Abstract]   [Full Text] [Related]  

  • 4. Turning off the switch in medulloblastoma: the inhibitory acetylation of an oncogene.
    Canettieri G; Di Marcotullio L; Coni S; Greco A; Gulino A
    Cell Cycle; 2010 Jun; 9(11):2047-8. PubMed ID: 20505339
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeted therapy done right: Direct sonic hedgehog inhibition for sonic hedgehog medulloblastoma.
    Nellan A; Jackson S
    Neuro Oncol; 2024 Apr; 26(4):623-624. PubMed ID: 38290484
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood-Brain Barrier Breakdown Determines Differential Therapeutic Outcome in Genetically Diverse Forms of Medulloblastoma.
    Guerit S; Liebner S
    Cancer Cell; 2016 Apr; 29(4):427-429. PubMed ID: 27070693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHH inhibitors for the treatment of medulloblastoma.
    Samkari A; White J; Packer R
    Expert Rev Neurother; 2015; 15(7):763-70. PubMed ID: 26027634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma.
    Faria CC; Golbourn BJ; Dubuc AM; Remke M; Diaz RJ; Agnihotri S; Luck A; Sabha N; Olsen S; Wu X; Garzia L; Ramaswamy V; Mack SC; Wang X; Leadley M; Reynaud D; Ermini L; Post M; Northcott PA; Pfister SM; Croul SE; Kool M; Korshunov A; Smith CA; Taylor MD; Rutka JT
    Cancer Res; 2015 Jan; 75(1):134-46. PubMed ID: 25391241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medulloblastoma: signalling a change in treatment.
    Gilbertson RJ
    Lancet Oncol; 2004 Apr; 5(4):209-18. PubMed ID: 15050952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma.
    Singh AR; Joshi S; Zulcic M; Alcaraz M; Garlich JR; Morales GA; Cho YJ; Bao L; Levy ML; Newbury R; Malicki D; Messer K; Crawford J; Durden DL
    PLoS One; 2016; 11(3):e0150836. PubMed ID: 26938241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis.
    Li Y; Song Q; Day BW
    Acta Neuropathol Commun; 2019 Jul; 7(1):123. PubMed ID: 31362788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hitting the target in medulloblastoma therapy.
    Bradbury J
    Drug Discov Today; 2004 Dec; 9(23):994-5. PubMed ID: 15574311
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of SHH pathway mechanisms by arsenic trioxide in pediatric medulloblastomas: a comprehensive literature review.
    Klinger PH; Andrade AF; Delsin LE; Queiroz RG; Scrideli CA; Tone LG; Valera ET
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28218785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting medulloblastoma: small-molecule inhibitors of the Sonic Hedgehog pathway as potential cancer therapeutics.
    Romer J; Curran T
    Cancer Res; 2005 Jun; 65(12):4975-8. PubMed ID: 15958535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN loss mitigates the response of medulloblastoma to Hedgehog pathway inhibition.
    Metcalfe C; Alicke B; Crow A; Lamoureux M; Dijkgraaf GJ; Peale F; Gould SE; de Sauvage FJ
    Cancer Res; 2013 Dec; 73(23):7034-42. PubMed ID: 24154871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medulloblastoma growth inhibition by hedgehog pathway blockade.
    Berman DM; Karhadkar SS; Hallahan AR; Pritchard JI; Eberhart CG; Watkins DN; Chen JK; Cooper MK; Taipale J; Olson JM; Beachy PA
    Science; 2002 Aug; 297(5586):1559-61. PubMed ID: 12202832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cynanbungeigenin C and D, a pair of novel epimers from Cynanchum bungei, suppress hedgehog pathway-dependent medulloblastoma by blocking signaling at the level of Gli.
    Li XY; Zhou LF; Gao LJ; Wei Y; Xu SF; Chen FY; Huang WJ; Tan WF; Ye YP
    Cancer Lett; 2018 Apr; 420():195-207. PubMed ID: 29425683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restore the brake on tumor progression.
    Gordon RE; Zhang L; Yang ZJ
    Biochem Pharmacol; 2017 Aug; 138():1-6. PubMed ID: 28389227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A five-gene hedgehog signature developed as a patient preselection tool for hedgehog inhibitor therapy in medulloblastoma.
    Shou Y; Robinson DM; Amakye DD; Rose KL; Cho YJ; Ligon KL; Sharp T; Haider AS; Bandaru R; Ando Y; Geoerger B; Doz F; Ashley DM; Hargrave DR; Casanova M; Tawbi HA; Rodon J; Thomas AL; Mita AC; MacDonald TJ; Kieran MW
    Clin Cancer Res; 2015 Feb; 21(3):585-93. PubMed ID: 25473003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hedgehog pathway and neurological disorders.
    Dellovade T; Romer JT; Curran T; Rubin LL
    Annu Rev Neurosci; 2006; 29():539-63. PubMed ID: 16776596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.